Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Litman

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Clinical Neuropharmacology|January 1, 1992
Regional brain metabolism as predictors of clozapine responseD Pickar, J K Hsiao, R E Litman
Drug Safety|December 1, 1993
Adverse effects of antipsychotic drugsA K Malhotra, R E Litman, D Pickar
Community Mental Health Journal|January 1, 1988
Youth suicide in California: a comparative study of perceived causes and interventionsF L Nelson, N L Farberow, R E Litman
Life Sciences|January 1, 1991
The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patientsP E Konicki, R R Owen, R E Litman, et al.
Suicide & Life-Threatening Behavior|January 1, 1992
Outpatient standards of care and the suicidal patientB Bongar, R W Maris, A L Berman, et al.
Schizophrenia Research|May 1, 1994
Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophreniaR E Litman, D W Hommer, A Radant, et al.
Community Mental Health Journal|November 5, 2013
The role of nonprofessional volunteers in a Suicide Prevention CenterS M Heilig, N L Farberow, R E Litman, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1990
Neurochemical and neural mechanisms of positive and negative symptoms in schizophreniaD Pickar, R E Litman, P E Konicki, et al.
The Journal of Clinical Psychiatry|September 1, 1994
Predictors of clozapine response in schizophreniaD Pickar, R R Owen, R E Litman, et al.
Suicide & Life-Threatening Behavior|January 1, 1993
Inpatient standards of care and the suicidal patient. Part I: General clinical formulations and legal considerationsB Bongar, R W Maris, A L Berman, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Clinical Neuropharmacology|January 1, 1992
Regional brain metabolism as predictors of clozapine responseD Pickar, J K Hsiao, R E Litman
Drug Safety|December 1, 1993
Adverse effects of antipsychotic drugsA K Malhotra, R E Litman, D Pickar
Community Mental Health Journal|January 1, 1988
Youth suicide in California: a comparative study of perceived causes and interventionsF L Nelson, N L Farberow, R E Litman
Life Sciences|January 1, 1991
The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patientsP E Konicki, R R Owen, R E Litman, et al.
Suicide & Life-Threatening Behavior|January 1, 1992
Outpatient standards of care and the suicidal patientB Bongar, R W Maris, A L Berman, et al.
Schizophrenia Research|May 1, 1994
Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophreniaR E Litman, D W Hommer, A Radant, et al.
Community Mental Health Journal|November 5, 2013
The role of nonprofessional volunteers in a Suicide Prevention CenterS M Heilig, N L Farberow, R E Litman, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1990
Neurochemical and neural mechanisms of positive and negative symptoms in schizophreniaD Pickar, R E Litman, P E Konicki, et al.
The Journal of Clinical Psychiatry|September 1, 1994
Predictors of clozapine response in schizophreniaD Pickar, R R Owen, R E Litman, et al.
Suicide & Life-Threatening Behavior|January 1, 1993
Inpatient standards of care and the suicidal patient. Part I: General clinical formulations and legal considerationsB Bongar, R W Maris, A L Berman, et al.
Pageof 4